Detalles de la búsqueda
1.
Pazopanib as Second-line Antiangiogenic Treatment in Metastatic Renal Cell Carcinoma After Tyrosine Kinase Inhibitor (TKI) Failure: A Phase 2 Trial Exploring Immune-related Biomarkers for Testing in the Post-immunotherapy/TKI Era.
Eur Urol Oncol
; 4(3): 502-505, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31477526
2.
Phase II clinical trial with metronomic oral vinorelbine and tri-weekly cisplatin as induction therapy, subsequently concomitant with radiotherapy (RT) in patients with locally advanced, unresectable, non-small cell lung cancer (NSCLC). Analysis of survival and value of ctDNA for patient selection.
Lung Cancer
; 153: 25-34, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33453470
Resultados
1 -
2
de 2
1
Próxima >
>>